Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4

E-ISSN： 1873-4286|14|10|990-1000

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.10, 2008-04, pp. : 990-1000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs

By Zhou Shufeng

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 279-304

Adis International

Access to resources Recommend Favorite

Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4

Current Drug Metabolism, Vol. 5, Iss. 5, 2004-01 ,pp. : 415-442

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism-Based Inactivators as Probes of Cytochrome P450 Structure and Function

Current Drug Metabolism, Vol. 2, Iss. 3, 2001-09 ,pp. : 215-243

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of Kinetic Parameters for Drug Oxidation Rates and Substrate Inhibition Potential Mediated by Cytochrome P450 3A4 and 3A5

Current Drug Metabolism, Vol. 9, Iss. 1, 2008-01 ,pp. : 20-33

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition

By Dresser G.K.

Clinical Pharmacokinetics, Vol. 38, Iss. 1, 2000-01 ,pp. : 41-57

Adis International

Access to resources Recommend Favorite